- Home
- NNAVW vs MRK Comparison
NNAVW vs MRK Comparison
Compare NNAVW & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNAVW | MRK |
|---|---|---|
| Founded | 2007 | 2000 |
| Country | United States | United States |
| Employees | 96 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 260.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NNAVW | MRK |
|---|---|---|
| Price | $7.07 | $100.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $109.13 |
| AVG Volume (30 Days) | 53.1K | ★ 15.8M |
| Earning Date | 03-12-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 3.39% |
| EPS Growth | N/A | ★ 58.08 |
| EPS | N/A | ★ 7.56 |
| Revenue | $4,963,000.00 | ★ $64,235,000,000.00 |
| Revenue This Year | N/A | $1.97 |
| Revenue Next Year | N/A | $4.96 |
| P/E Ratio | ★ N/A | $13.27 |
| Revenue Growth | ★ 43.44 | 1.68 |
| 52 Week Low | $4.47 | $73.31 |
| 52 Week High | $4.70 | $105.84 |
Technical Indicators
Market Signals| Indicator | NNAVW | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 68.31 | 60.29 |
| Support Level | $6.91 | $96.06 |
| Resistance Level | $7.51 | $99.85 |
| Average True Range (ATR) | 0.37 | 2.44 |
| MACD | 0.16 | -0.62 |
| Stochastic Oscillator | 78.93 | 45.43 |
Price Performance
Historical ComparisonAbout NNAVW NextNav Inc. Warrant
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).